lung carcinoma in situ
Human disease
Press Enter · cited answer in seconds
0 sources
lung carcinoma in situ
Summary
lung carcinoma in situ is a class of disease[1].
Key Facts
- lung carcinoma in situ's instance of is recorded as class of disease[2].
- lung carcinoma in situ is a type of in situ carcinoma[3].
- lung carcinoma in situ is a type of lung disease[4].
- lung carcinoma in situ is a type of lung neoplasm[5].
- lung carcinoma in situ's anatomical location is recorded as human lung[6].
- lung carcinoma in situ's ICD-9-CM is recorded as 231.2[7].
- lung carcinoma in situ's NCI Thesaurus ID is recorded as C27467[8].
- lung carcinoma in situ's health specialty is recorded as oncology[9].
- lung carcinoma in situ's drug or therapy used for treatment is recorded as pegfilgrastim[10].
- lung carcinoma in situ's drug or therapy used for treatment is recorded as erlotinib[11].
- lung carcinoma in situ's drug or therapy used for treatment is recorded as gefitinib[12].
- lung carcinoma in situ's drug or therapy used for treatment is recorded as osimertinib[13].
- lung carcinoma in situ's drug or therapy used for treatment is recorded as ceritinib[14].
- lung carcinoma in situ's exact match is recorded as http://purl.obolibrary.org/obo/DOID_8800[15].
- lung carcinoma in situ's exact match is recorded as http://identifiers.org/doid/DOID:8800[16].
- lung carcinoma in situ's on focus list of Wikimedia project is recorded as WikiProject Medicine[17].